blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2753347

EP2753347 - TREATMENT OF ALLODYNIA, HYPERALGSIA, SPONTANEOUS PAIN, AND PHANTOM PAIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.06.2017
Database last updated on 26.07.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
NsGene A/S
Baltorpvej 154
2750 Ballerup / DK
[2014/29]
Inventor(s)01 / JØRGENSEN, Jesper Roland
Mariendalsvej 73
2.tv.
DK-2000 Frederiksberg / DK
02 / WAHLBERG, Lars Ulrik
259 Riverside Dr.
Tiverton, Rhode Island 02878 / US
03 / JOHANSEN, Teit E.
Stampeengen 26
DK-2970 Hørsholm / DK
 [2014/29]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2016/31]Høiberg A/S
Adelgade 12
1304 Copenhagen K / DK
Former [2014/29]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date12766380.505.09.2012
[2016/31]
WO2012DK50330
Priority number, dateUS201161531024P05.09.2011         Original published format: US 201161531024 P
[2014/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013034157
Date:14.03.2013
Language:EN
[2013/11]
Type: A1 Application with search report 
No.:EP2753347
Date:16.07.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 14.03.2013 takes the place of the publication of the European patent application.
[2014/29]
Type: B1 Patent specification 
No.:EP2753347
Date:03.08.2016
Language:EN
[2016/31]
Search report(s)International search report - published on:EP14.03.2013
ClassificationIPC:A61K38/17, C12N5/00
[2014/29]
CPC:
A61K38/185 (EP,US); A61K38/17 (EP,US); A61K9/0085 (US);
A61P25/00 (EP); A61P25/02 (EP); A61P25/04 (EP);
A61P29/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/29]
Extension statesBA07.04.2014
ME07.04.2014
TitleGerman:BEHANDLUNG VON ALLODYNIE, HYPERALGESIE, SPONTANEN SCHMERZEN UND PHANTOMSCHMERZEN[2014/29]
English:TREATMENT OF ALLODYNIA, HYPERALGSIA, SPONTANEOUS PAIN, AND PHANTOM PAIN[2014/29]
French:TRAITEMENT DE L'ALLODYNIE, DE L'HYPERALGIE, DE LA DOULEUR SPONTANÉE ET DE LA DOULEUR ILLUSIONNELLE[2014/29]
Entry into regional phase07.04.2014National basic fee paid 
07.04.2014Designation fee(s) paid 
07.04.2014Examination fee paid 
Examination procedure04.07.2013Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.04.2014Examination requested  [2014/29]
29.10.2014Amendment by applicant (claims and/or description)
27.04.2015Despatch of a communication from the examining division (Time limit: M06)
04.11.2015Reply to a communication from the examining division
16.02.2016Communication of intention to grant the patent
22.06.2016Fee for grant paid
22.06.2016Fee for publishing/printing paid
22.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.04.2015
Opposition(s)04.05.2017No opposition filed within time limit [2017/28]
Fees paidRenewal fee
01.09.2014Renewal fee patent year 03
03.09.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.09.2012
AL03.08.2016
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
TR03.08.2016
IE05.09.2016
LU05.09.2016
CH30.09.2016
LI30.09.2016
MT30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
[2018/46]
Former [2018/45]HU05.09.2012
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
TR03.08.2016
IE05.09.2016
LU05.09.2016
CH30.09.2016
LI30.09.2016
MT30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2018/31]HU05.09.2012
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
LU05.09.2016
CH30.09.2016
LI30.09.2016
MT30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2018/28]HU05.09.2012
AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
LU05.09.2016
CH30.09.2016
LI30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/40]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
LU05.09.2016
CH30.09.2016
LI30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/37]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
CH30.09.2016
LI30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/35]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
CH30.09.2016
LI30.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/32]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
SM03.08.2016
IE05.09.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/23]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
SM03.08.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/23]AT03.08.2016
BE03.08.2016
CZ03.08.2016
EE03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/13]AT03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE30.09.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/11]AT03.08.2016
ES03.08.2016
FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE30.09.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/10]FI03.08.2016
HR03.08.2016
IT03.08.2016
LT03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE30.09.2016
NO03.11.2016
IS03.12.2016
Former [2017/09]FI03.08.2016
IT03.08.2016
LT03.08.2016
NL03.08.2016
NO03.11.2016
Former [2017/07]LT03.08.2016
Cited inInternational search[XDI]WO2010009732  (NSGENE AS [DK], et al) [XD] 1-28,37-43,45,46,56-62 * page 36, line 2; claims 1,17,37,42,51; sequences 2,7,10 * [I] 29-36,44,47-55;
 [XP]WO2012041328  (NSGENE AS [DK], et al) [XP] 1-8,10-62 * claims 1,29,27,38; sequence 3 *;
 [A]  - NISHINO J ET AL, "Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, (20040505), vol. 23, no. 9, doi:10.1038/SJ.EMBOJ.7600202, ISSN 0261-4189, pages 1998 - 2008, XP002334608 [A] 1-62 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.emboj.7600202
by applicantUS4407957
 US4868116
 US4892538
 US5106627
 US5156844
 WO9219195
 US5219990
 WO9322437
 US5283187
 WO9505452
 US5399346
 US5460959
 US5550050
 US5554148
 US5639275
 US5653975
 WO9734586
 US5677158
 US5798113
 US5800828
 WO0139786
 US6309634
 WO02078730
 US6683058
 WO2005095450
 WO2007100898
 WO2010009732
    - THOMPSON, J.D.; HIGGINS, D.G.; GIBSON, T.J., "CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice", NUCLEIC ACIDS RESEARCH, (1994), vol. 22, pages 4673 - 4680, XP002956304
    - HIGGINS D.; THOMPSON J.; GIBSON T.; THOMPSON J.D.; HIGGINS D.G.; GIBSON T.J., "CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice", NUCLEIC ACIDS RES., (1994), vol. 22, pages 4673 - 4680, XP002956304
    - PEARSON WR, METHODS MOL BIOL, (2000), vol. 132, pages 185 - 219
    - REAGAN-SHAW ET AL., FASEB J, (2007), vol. 22, pages 659 - 661
    - JØRGENSEN ET AL., EXP NEUROL, (2012), vol. 233, pages 172 - 81
    - WOLD, F., Posttranslational Covalent Modification of Proteins, ACADEMIC PRESS, (1983), pages 1 - 12
    - SEIFTER ET AL., METH. ENZYMOL., (1990), vol. 182, pages 626 - 646
    - RATTAN ET AL., "Protein Synthesis: Posttranslational Modifications and Aging", ANN. N.Y. ACAD. SCI., (1992), vol. 663, doi:doi:10.1111/j.1749-6632.1992.tb38648.x, pages 48 - 62, XP009082490

DOI:   http://dx.doi.org/10.1111/j.1749-6632.1992.tb38648.x
    - KUPERS,R.; YU,W.; PERSSON,J.K.; XU,X.J.; WIESENFELD-HALLIN,Z., "Photochemically-induced ischemia of the rat sciatic nerve produces a dose-dependent and highly reproducible mechanical, heat and cold allodynia, and signs of spontaneous pain", PAIN, (1998), vol. 76, pages 45 - 59
    - STORKSON,R.V.; KJORSVIK,A.; TJOLSEN,A.; HOLE,K., "Lumbar catheterization of the spinal subarachnoid space in the rat", J. NEUROSCI. METHODS, (1996), vol. 65, pages 167 - 172
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.